Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Histopathology|July 16, 2016
Range of pathologies diagnosed using a minimally invasive capsule sponge to evaluate patients with reflux symptomsAnna L Paterson, Pierre Lao-Sirieix, Maria O'Donovan, et al.
British Journal of Cancer|October 21, 2015
Molecular effects of Lapatinib in the treatment of HER2 overexpressing oesophago-gastric adenocarcinomaNadeera De Silva, Laura Schulz, Anna Paterson, et al.
Nature Medicine|January 17, 2012
Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett's esophagusElizabeth L Bird-Lieberman, André A Neves, Pierre Lao-Sirieix, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 13, 2021
Utility and Cost-Effectiveness of a Nonendoscopic Approach to Barrett's Esophagus Surveillance After Endoscopic TherapySwathi Eluri, Anna Paterson, Brianna N Lauren, et al.
Gastrointestinal Endoscopy|July 10, 2017
Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation statusEmma Z Mi, Ella Z Mi, Massimiliano di Pietro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2012
DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagusMuhammad A Alvi, Xinxue Liu, Maria O'Donovan, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancersAmel Saadi, Nicholas B Shannon, Pierre Lao-Sirieix, et al.
BMJ (Clinical Research Ed.)|September 14, 2010
Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort studySudarshan R Kadri, Pierre Lao-Sirieix, Maria O'Donovan, et al.
Lancet (London, England)|August 3, 2020
Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trialRebecca C Fitzgerald, Massimiliano di Pietro, Maria O'Donovan, et al.
Nature Communications|March 12, 2024
Enabling large-scale screening of Barrett's esophagus using weakly supervised deep learning in histopathologyKenza Bouzid, Harshita Sharma, Sarah Killcoyne, et al.
Pageof 9